| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |